1. Antisense oligonucleotide-mediated disruption of HTT caspase-6 cleavage site ameliorates the phenotype of YAC128 Huntington disease mice
   Elsa C. Kuijper et al, 2024, Neurobiology of Disease CrossRef
2. Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
   Alaa Shafie et al, 2024, Archives of Pharmacal Research CrossRef
3. Role of PIN1 in human pathology: Cellular regulation, pathogenesis and therapeutic implications (Review)
   Julian Maggio et al, 2023, World Academy of Sciences Journal CrossRef
4. UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting
   Soho Oyama et al, 2024, Neurology International CrossRef
5. Huntington’s Disease: Understanding Its Novel Drugs and Treatments
   Hitaansh Dhingra et al, 2023, Cureus CrossRef
6. Recombinant Antibody Fragments for Neurological Disorders: An Update
   Karen Manoutcharian et al, 2024, Current Neuropharmacology CrossRef
7. Pathophysiology and Management Approaches for Huntington’s Disease, Multiple Sclerosis, and Other Neurological Disorder
   Chetana Ahire et al, 2023, Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities CrossRef
8. Cellular Compartmentalization, Glutathione Transport and Its Relevance in Some Pathologies
   Héctor Vázquez-Meza et al, 2023, Antioxidants CrossRef
9. Reversing memory/cognitive impairment with medicinal plants targeting inflammation and its crosstalk with other pathologies
   Sheena E.B. Tyler et al, 2023, Brain Disorders CrossRef
10. Neurolipid systems: A new target for the treatment of dementia
    Gorka Pereira‐Castelo et al, 2024, Basic & Clinical Pharmacology & Toxicology CrossRef